Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- The Rosen Law Firm PAROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMSWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"), of the important November 2, 2026 lead plaintiff deadline.SO WHAT: If you purchased Hims securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement....
- Helus Pharma NEW YORK andHelus Pharma to Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry SummitCEO Michael Halstead to participate in a fireside chat on September 23, 2026 at 9:00 a.m. EDT
- BD (Becton, Dickinson and Company)Arthur Hu to Join BD as Chief Information and Digital OfficerCompanies: Becton DickinsonBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Arthur (Art) Hu has been named executive vice president and chief information and digital officer, effective September 30....
- Travere Therapeutics, Inc.Travere Therapeutics Announces Planned Chief Executive Officer TransitionSAN DIEGO, September 21, 2026--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that Eric Dube, Ph.D., has made the difficult and personal decision to step down as president and chief executive officer to focus on his health and family. The Company’s Board of Directors has unanimously appointed Bradley L.
- The Inner CircleThe Inner Circle acknowledges Ms. Adria Nadine Ross, as a Pinnacle Professional of The YearProminently featured in The Inner Circle, Adria Nadine Ross is acknowledged as a Pinnacle Professional of The Year for her contributions to Holistic Health and Energy Medicine. Adria Nadine Ross has built a distinguished career in holistic...
- Alzinova Advances Dual Approach to Alzheimer’s Treatment and Diagnosis as World Alzheimer’s Day Highlights Unmet NeedOn World Alzheimer’s Day, Swedish biotech Alzinova highlights progress in Alzheimer’s treatment and diagnostics as ALZ-101 enters Phase II start-up.
- ABL Texcell Diagnostics Reaches a New Strategic Milestone With a Proposed Acquisition of Vela Diagnostics' Activities in Singapore and the United StatesWOIPPY, France, September 21, 2026--Regulatory News: ABL Diagnostics (Euronext Paris: ABLD – ISIN: FR001400AHX6) (the "Company"), a company specializing in molecular diagnostic solutions, healthcare software and clinical research services, announces that it has signed, alongside Advanced Biological Laboratories S.A. (ABL), its parent company, a non-binding letter of intent for a proposed acquisition of 100% of the share capital of Vela Operations Singapore Pte. Ltd.
- MaaT Pharma Announces Upcoming Pre-IND Meeting with the FDA and Advances MaaT034 Toward Clinical Development in Solid TumorsLYON, France, September 21, 2026--MaaT Pharma Announces Upcoming Pre-IND Meeting with the FDA and Advances MaaT034 Toward Clinical Development in Solid Tumors
- Medical Precision Inc.Dutch Medical Device Maker, Medical Precision, Enters U.S. Market With FDA-Cleared Comfort MarkerSCOTTSDALE, Ariz., September 21, 2026--Medical Precision Inc., a Dutch medical device company, today announced its official entry into the United States market with its flagship product, the Comfort Marker, an FDA De Novo-cleared device that allows radiotherapy teams to place patient reference points with significantly less pain and discomfort than traditional marking methods. The company is looking forward to introducing itself and highlighting the product to U.S. clinicians at the American Soc
- Zealand Pharma - Transactions related to share buy-back program (week 38, 2026)Company announcement No. 49 / 2026
- Siemens Healthineers and Novo Join Forces to Advance Care for People Living with MASLD and MASHCompanies: Siemens HealthineersSiemens Healthineers and Novo have announced a collaboration focused on advancing care for people living with metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH). The companies are engaged in several projects to strengthen disease awareness, support earlier assessment of the disease, and help expand patient access to non-invasive blood testing.
- External Review and Appeals: How Independent Medical Review Strengthens Clinical Integrity and DefensibilityBHM Healthcare Solutions on how accredited independent medical review strengthens the clinical integrity and defensibility of payer determinations